anthonyyazdaniml/gliner-biomed-curated-corpus huggingface dataset:
OBJECTIVES: To explore the postmortem diffusion rule of Aconitum alkaloids and their metabolites in poisoned rabbits, and to provide a reference for identifying the antemortem poisoning or postmortem poisoning of Aconitum alkaloids.
METHODS: Twenty-four rabbits were sacrificed by tracheal clamps. After 1 hour, the rabbits were administered with aconitine LD50 in decocting aconite root powder by intragastric administration. Then, they were placed supine and stored at 25 ℃. The biological samples from 3 randomly selected rabbits were collected including heart blood, peripheral blood, urine, heart, liver, spleen, lung and kidney tissues at 0 h, 4 h, 8 h, 12 h, 24 h, 48 h, 72 h and 96 h after intragastric administration, respectively. Aconitum alkaloids and their metabolites in the biological samples were analyzed by high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS).
RESULTS: At 4 h after intragastric administration, Aconitum alkaloids and their metabolites could be detected in heart blood, peripheral blood and major organs, and the contents of them changed dynamically with the preservation time. The contents of Aconitum alkaloids and their metabolites were higher in the spleen, liver and lung, especially in the spleen which was closer to the stomach. The average mass fraction of benzoylmesaconine metabolized in rabbit spleen was the highest at 48 h after intragastric administration. In contrast, the contents of Aconitum alkaloids and their metabolites in kidney were all lower. Aconitum alkaloids and their metabolites were not detected in urine.
CONCLUSIONS: Aconitum alkaloids and their metabolites have postmortem diffusion in poisoned rabbits, diffusing from high-content organs (stomach) to other major organs and tissues as well as the heart blood. The main mechanism is the dispersion along the concentration gradient, while urine is not affected by postmortem diffusion, which can be used as the basis for the identification of antemortem and postmortem Aconitum alkaloids poisoning.
Angiogenesis, or the development of new blood vessels, appears to be one of the keys to tumor survival. Areas of new blood vessel growth, or neovascularization, such as with trauma or tissue ischemia, appear to release factors that stimulate production of endothelial cells from progenitor stem cells located in the bone marrow. Endothelial cells for the inside lining of blood vessels are important in the formation of viable and functional blood vessel conduits. Recent work suggests that tumors-including primary brain tumors-secrete many of the same stimulatory growth factors as normally incite endothelial cells to be produced and turned out into the circulation. Initial evidence suggests that these circulating endothelial progenitor cells (EPCs) play a role in the impressive neovascularization seen with tumors. In this study, we wish to investigate the interaction of gliomas and EPCs to elucidate a potential role for EPCs in tumor formation, response to therapy, progression, and overall survival, as well, to identify potential new targets for anti-tumor and/or anti-angiogenic therapies using genomic and proteomic techniques.

Patients suspected of having, or with prior biopsy proof of, a WHO grade II-IV central nervous system (CNS) glial tumor(s) seen in the Surgical Neurology Branch, NINDS, will be considered for entry into this study. Tissue samples of tumor resected as part of standard care will be collected at surgery and preserved for research. Blood samples will also be collected. Blood will also be collected from anonymous normal volunteers who donate blood at the NIH Blood Bank; these anonymous donors will serve as controls.
The present invention relates in a first aspect to a polypeptide complex comprising IL-6 and a soluble IL-6 receptor or a nucleic acid sequence encoding the same for use as an adjuvant. It has been recognized that the polypeptide complex comprising IL-6 and a soluble IL-6 receptor, in particular, Hyper-IL-6, represents an adjuvant directly acting on T-cells. It is submitted that the polypeptide or a nucleic acid sequence encoding the same according to the present invention represents the first direct acting T-cell adjuvant described in the art. In another aspect, the present invention relates to a pharmaceutical composition comprising the polypeptide complex or a nucleic acid sequence encoding the same comprising IL-6 and a soluble IL-6 receptor according to the present invention as an adjuvant, a pharmaceutical active ingredient and, optionally, additional components whereby the pharmaceutical composition is a therapeutic or prophylactic vaccine. Finally, the present invention relates to the use of the polypeptide or a nucleic acid sequence encoding the same according to the present invention comprising IL-6 and a soluble IL-6 receptor for activation of effector and memory T-cells in a subject, in particular, in a human. Particularly, the T-cells are cytotoxic T-cells, CD8 +  T-cells.
The study is designed as a randomized controlled trial to compare two methods to guide application of clinical interventions after planned extubation: SMT versus IPI based clinical management among adult patients admitted in the ICU and receiving mechanical ventilation for ≥24 hours. Each mechanically ventilated subject within the inclusion criteria and with a physician order for extubation will be randomized to either the SMT or IPI based clinical management group. Once the extubation order is placed by the medical team, the patient will be randomized to IPI monitoring group or standard medical management group. Patients randomized to IPI group will be placed on IPI monitoring after extubation.Respiratory Therapist (RT) will extubate and connects the patient to EtCO2 cannula (Medtronic, Minneapolis, MN) and will turn on IPI monitoring on the Philips monitor. Any subject with decrease in IPI by 1 within 1 hour of extubation or IPI ≤ 4 after 1 hour of extubation will be assessed by RT and will receive standard medical therapy based on respiratory department protocols. IPI monitoring will be continued for up to 72 hours after extubation. Patients randomized to control group will receive standard medical therapy based on the respiratory department protocols. All patients will be clinically monitored for 72 hours after extubation to assess the extubation outcome. Patients that require reintubation will be reintubated based on the medical team decision and will be discontinued from the study. Patients that do not require reintubation after 72 hours will successfully complete the study.
Acute mesenteric ischemia is a condition characterized by non-specific presentation (typical clinical presentation is considered "abdominal pain out of proportion to examination") that may be under-recognized in the Emergency Department. Early identification and treatment is essential to improve outcome as mortality rate is attested around 80% if untreated within few hours from onset. The investigators aim to review the emergency department's clinical notes of patients discharged from hospital in 2014 and 2015 diagnosed with acute mesenteric ischemia. Furthermore the investigators will consider patients admitted for "abdominal pain" in the same time frame without acute mesenteric ischemia and we will compare presentation symptoms, medical history, medications, vitals, laboratory markers and imaging finding of the two groups. From this comparison, the investigators will be able to clarify the incidence among general population and among patients presenting acute abdominal pain. Finally, using multivariate analysis, the investigators may identify those variables predictive of acute mesenteric ischemia. This study will be held in three university hospitals and all data analyzed together.
Recently, thyroid autoantibodies were found to be associated with moyamoya disease (MMD). The ring finger protein 213 (RNF213) p.R4810K variant represents the most important susceptibility genotype of this disease, but its relationship with thyroid autoantibodies remains to be elucidated. Thus, in this study, we aimed to evaluate the clinical relevance of thyroid autoantibodies in each RNF213 genotype in patients with MMD. Included in this study were patients with MMD without a thyroid disease history and in euthyroid status; they were then classified into the mutated or nonmutated based on the RNF213 p.R4810K genotype and positive or negative based on thyroid autoantibody (thyroperoxidase and thyroglobulin) levels. Clinical data of each group were thereafter evaluated. Among the 209 patients, the mutated RNF213 p.R4810K variant and positive thyroid autoantibodies were detected in 155 and 41 patients, respectively. Positive thyroid autoantibodies were found to be more common in the nonmutated patients than in the mutated patients (31.5% vs. 15.5%; P = 0.011). In the mutated patients, as compared to autoantibody-negative patients, autoantibody-positive patients were determined to be more likely to have advanced disease with posterior cerebral artery involvement (54.2% vs. 29.0%; P = 0.017), white matter infarction (58.3% vs. 37.6%; P = 0.046), and a higher modified Rankin Scale at last visit (16.7% vs. 3.1%; P = 0.021). These results suggest that thyroid autoantibodies can act as an immunity inducer in patients with MMD lacking the susceptibility gene RNF213 p.R4810K variant. Moreover, the simultaneous presence of thyroid autoantibodies and the variant seems to aggravate the disease, which indicates synergy between thyroid autoantibodies and the variant.
AIMS: Acute kidney injury (AKI) is a public health problem and represents a risk factor for cardiovascular diseases (CVD) and vascular damage. This study aimed to investigate the impact of AKI on purinergic components in mice aorta.
MAIN METHODS: The kidney ischemia was achieved by the occlusion of the left kidney pedicle for 60 min, followed by reperfusion for 8 (IR8) and 15 (IR15) days. Renal function was assessed through biochemical assays, while gene expression levels were evaluated by RT-qPCR.
KEY FINDINGS: Analyses of renal parameters showed renal remodeling through mass loss in the left kidney and hypertrophy of the right kidney in the IR15 group. Furthermore, after 15 days, local inflammation was evidenced in the aorta. Moreover, the aorta purinergic components were significantly impacted by the renal ischemia and reperfusion model, with increases in gene expression of the pro-inflammatory purinoceptors P2Y1, P2Y2, P2Y6, and P2X4, potentially contributing to the vessel inflammation. The expression of NTPDase2 and ecto-5'-nucleotidase were also significantly increased in the aorta of the same group. In addition, both ATP and AMP hydrolysis were significantly increased in the aorta from IR15 animals, driving the entire purinergic cascade to the production of the anti-inflammatory adenosine.
SIGNIFICANCE: In short, this is the first time that inflammation of the aorta due to AKI was shown to have an impact on purinergic signaling components, with emphasis on the adenosinergic pathway. This seems to be closely implicated in the establishment of vascular inflammation in this model of AKI and deserves to be further investigated.
A skin cleaning composition for use without addition of water comprises (a) an organic solvent for skin contaminants, suitably a mineral oil of cosmetic grade, (b) a non-ionic surface active agent which is preferably a condensate of 2-20 mols of ethylene oxide with 1 mol of a fatty acid having 12-22 carbon atoms in the alkyl chain, (c) a synthetic hydrophilic acid polymer colloid thickening agent other than a cellulose derivative and (d) water, the composition having a pH of 5-7. (c) is suitably a copolymer of about 99% by weight of acrylic acid or a homologue thereof and about 1% of a polyallyl sucrose in which the sucrose molecule has 5-6 allyl groups. Sodium hydroxide is generally added to the composition to neutralize the acidity of this constituent.  The composition is produced in a creamy form by dissolving the surface active agent in the solvent and the colloid in the water and mixing the solutions.  The breaking qualities of the composition are improved by incorporating small quantities (up to 2%) of tertiary amines having one alkyl group and two polyoxyethylene groups attached to the amino nitrogen atom. Corrosion inhibitors such as oleoyl sarcosine and 2-hydroxypropylamine nitrite, and anti-evaporants such as propylene or diethylene glycol are also desirably incorporated.
High vegetable consumption is associated with maintenance of a healthy body weight. Americans do not eat vegetables in the amounts recommended by the dietary guidelines and interventions to increase intake have had limited results. Reported barriers to consumption include not knowing how to prepare them and being unused to eating them.To get people to eat vegetables, they have to be motivated to do so. Repeated consumption of snack foods increases overweight and obese individuals' motivation to eat snack foods. The investigators hypothesize that by increasing people's consumption of vegetables by making them easy to eat will increase the motivation value of vegetables. For this study the investigators propose to provide minimally-processed (cleaned, packaged) vegetables to overweight and obese individuals. The motivating value of vegetables will be measured using a computer task where people play a game to earn points towards portions of a vegetable or a neutral food (crackers). The investigators will determine potential moderators of the increase in the motivating value of vegetables such as genetics (single nucleotide polymorphisms) that are associated with the motivating value of food and whether people substitute eating vegetables for other foods. The investigators will also determine changes in adiposity as a result of vegetable consumption. Lastly, the investigators will determine if repeated consumption increases psychosocial predictors of vegetable intake, such as self-efficacy of eating vegetables.
Providing pigs with organic enrichment material is important for satisfying pigs' natural explorative behavior to prevent injurious tail biting and thus increase animal welfare in general. The aim of this study was to investigate the effects of automatically supplied enrichment material of three different types (alfalfa pellets, oat bran pellets, or a mixture of both) and different enrichment frequencies (2, 4, or 6 supplies/day) on the behavior, the occurrence of tail biting, and daily weight gains of weaner pigs. The results showed significant effects and interactions of enrichment material, frequency and the time of day on the exploratory behavior, the occurrence of tail biting, and daily weight gains. Higher probabilities for pigs using the enrichment material were observed for groups provided with only two supplies/day or receiving oat bran pellets. Additionally, more pigs explored the material when supplied in the afternoon compared to the morning. Tail lesions began to increase in week 4 of the rearing period. Higher probabilities of having a tail lesion were recorded in groups provided with two supplies/day compared to four or six supplies per day. Furthermore, the highest probabilities for pigs having a tail length loss at the end of the rearing period were shown by groups receiving two supplies/day, with 0.170 for alfalfa pellets, 0.342 for mixture, and 0.486 for oat bran pellets. For daily weight gains, only alfalfa groups differed significantly from mixture groups in the case of two supplies/day. No differences were observed for the other factor combinations. These results showed the potential of an automatic enrichment device supporting pigs in performing their natural exploratory behavior in a conventional housing system. Higher numbers of daily enrichment supplies show beneficial effects to reduce the occurrence of tail biting and tail length losses.
PROBLEM TO BE SOLVED: To provide a method for producing the subject agent by making use of familiar materials such as mugwort leaves and peach leaves as herbs which the Japanese have been fond of since early times, or SHOCHU (low-class distilled spirits). SOLUTION: This dermatophytosis therapeutic agent is obtained by the following process: First, 200g mugwort leaves dried in the shade, 300g peach leaves dried in the shade, and SHOCHU are prepared in advance. Secondly, the SHOCHU is put into an earthenware or enamelware pot followed by heating for about 30min while being kept at about 60 deg.C to expel an excess of alcohol fraction and then the heating is ceased. Thirdly, 100g of the mugwort leaves and 300g of the peach leaves are added to the resultant SHOCHU and the mixture is left to stand for about 30min. After sufficiently infiltrating the leaves with the SHOCHU, the mixture is heated again so as to maintain the temperature of about 40 deg.C for one hour or so to effect extraction of active ingredients. Subsequently, the heating is ceased and the mixture is cooled and then subjected to filtration.
Patients receive intraperitoneal denileukin diftitox over at least 15 minutes on days 1-3. Treatment repeats every 14 days for 4 courses in the absence of disease progression or unacceptable toxicity.
Participants 6 to 17 years of age with the non-neuronopathic form of mucopolysaccharidosis type II (nnMPS II). Clinical, neurocognitive, laboratory, and biomarker assessments will be conducted.
A cloud health management system combining the Internet of Things (IoT), including a cloud database unit, a health management unit, an IoT service unit, and a consulting unit. The health management unit includes an analysis module, which has several built-in reference data and is configured to perform comparative analysis on the health status data in the cloud database unit and to generate an analysis report. The IoT service unit includes a virtual reality device and a product explanation module. The virtual reality device includes a display communication module, a processing module, and a control module. The product explanation module includes a plurality of multimedia data that are used for the introduction and explanation of the functions and usage of certain products. The control module is used to select any multimedia data and display/play the multimedia data through the display communication module for the user to obtain the functions and usage of the products. The consulting unit is electrically connected to the health management unit and includes at least one consulting channel, which can be connected to a remote online service personnel through a processing module of the health management unit or the virtual reality device for online interactive consultation.
PURPOSE:To obtain an agent for the treatment of cataract as a diabetic complication by using conduritol A as an active component. CONSTITUTION:Conduritol A is used as an active component and formed in the form of a drug preparation by properly compounding with additives such as vehicle and stabilizer. The preferable amount of conduritol A is 5-80wt.% for granule, particle, powder, tablet or capsule and is 1-30wt.% for liquid drug or eye lotion. In the case of oral administration, the compound is preferably administered at a daily dose of 10-3,000mg of conduritol A for adult. Conduritol A can be produced by extracting dried leaf of Gymnema sylvestre or dried powder of condurango bark and purifying the extract. Conduritol A inhibits the activity of aldose reductase which is an enzyme to convert glucose into sorbitol.
Participants will receive up to 3.2 mg/m\^2 of neoadjuvant lurbinectedin IV once every cycle (a cycle is 21 days) in combination with 6 weeks of pre-operative conventional external beam radiation therapy given as 45-50.4 Gy delivered over 25-28 fractions starting on cycle 1 for participants with retroperitoneal sarcoma. Non-investigational surgery will take place 4-6 weeks after completion of radiation therapy. Participants with metastatic disease at the time of study enrollment may be able to continue study treatment for 2 years from the time of initiating treatment. Participants with localized disease at the time of study enrollment may continue study treatment for approximately 3 months AND then be followed on-study surveillance.
Bovine respiratory disease (BRD) causes major losses in feedlot cattle worldwide. A genetic component for BRD resistance in feedlot cattle and calves has been reported in a number of studies, with heritabilities ranging from 0.04 to 0.2. These results suggest selection could be used to reduce the incidence of BRD. Genomic selection could be an attractive approach for breeding for BRD resistance, given the phenotype is not likely to be recorded on breeding animals. In this study, we derived GEBVs for BRD resistance and assessed their accuracy in a reasonably large data set recorded for feedlot treatment of BRD (1213 Angus steers, in two feedlots). In fivefold cross validation, genomic predictions were moderately accurate (0.23 ± 0.01) when a BayesR approach was used. Expansion of this approach to include more animals and a diversity of breeds is recommended to successfully develop a GEBV for BRD resistance in feedlots for the beef industry.
The JNET classification, combined with magnified narrowband imaging (NBI), is essential for predicting the histology of colorectal polyps and guiding personalized treatment strategies. Despite its recognized utility, the diagnostic efficacy of JNET classification using NBI with dual focus (DF) magnification requires exploration in the Vietnamese context. This study aimed to investigate the diagnostic performance of the JNET classification with the NBI-DF mode in predicting the histology of colorectal polyps in Vietnam. A cross-sectional study was conducted at the University Medical Center in Ho Chi Minh City, Vietnam. During real-time endoscopy, endoscopists evaluated the lesion characteristics and recorded optical diagnoses using the dual focus mode magnification according to the JNET classification. En bloc lesion resection (endoscopic or surgical) provided the final pathology, serving as the reference standard for optical diagnoses. A total of 739 patients with 1353 lesions were recruited between October 2021 and March 2023. The overall concordance with the JNET classification was 86.9%. Specificities and positive predictive values for JNET types were: type 1 (95.7%, 88.3%); type 2A (81.4%, 90%); type 2B (96.6%, 54.7%); and type 3 (99.9%, 93.3%). The sensitivity and negative predictive value for differentiating neoplastic from non-neoplastic lesions were 97.8% and 88.3%, respectively. However, the sensitivity for distinguishing malignant from benign neoplasia was lower at 64.1%, despite a specificity of 95.9%. Notably, the specificity and positive predictive value for identifying deep submucosal cancer were high at 99.8% and 93.3%. In Vietnam, applying the JNET classification with NBI-DF demonstrates significant value in predicting the histology of colorectal polyps. This classification guides treatment decisions and prevents unnecessary surgeries.
Syncope can be caused by many conditions, often benign but in some cases syncope can be a symptom of severe arrhythmia. Early diagnosis of the underlying disease is very important to identify patients with severe cardiac arrhythmia to commence adequate treatment. Standard diagnostic methods such as 24 hours Holter electrocardiogram (ECG) monitoring or Event Holter do not guarantee early diagnosis of the arrhythmia. Prolonged heart rhythm recording and analysis using an automatic full disclosure telemetric device can increase probability of arrhythmia diagnosis and early administration of adequate treatment. Study patients will be diagnosed using standard Holter ECG monitoring, Event Holter or 30 days telemetric ECG monitoring. Efficacy of telemetric monitoring in diagnosis of cardiac arrhythmia will be assessed in comparison with the standard Holter monitoring and Event Holter.
The teeth were treated in two visit (TV) root canal treatment. After completion of root canal instrumentation, calcium hydroxide (CH) paste was placed into the root canal. In second visit, all root canals were irrigated with 5% EDTA followed by 2.5% NaOCl before obturation.